Accurate revenue calculation is critical in the pharmaceutical industry, where pricing complexity, regulatory oversight, and multiple deduction layers directly affect financial reporting and compliance. The Gross-to-Net (GTN) process sits at the center of this effort, translating gross sales into actual realized revenue by accounting for rebates, discounts, chargebacks, returns, and